SIMILAR TREATMENT SUCCESS RATE AFTER RENAL-TRANSPLANTATION IN DIABETIC AND NONDIABETIC PATIENTS DUE TO IMPROVED SHORT-TERM AND LONG-TERM DIABETIC PATIENT SURVIVAL
H. Ekberg et A. Christensson, SIMILAR TREATMENT SUCCESS RATE AFTER RENAL-TRANSPLANTATION IN DIABETIC AND NONDIABETIC PATIENTS DUE TO IMPROVED SHORT-TERM AND LONG-TERM DIABETIC PATIENT SURVIVAL, Transplant international, 9(6), 1996, pp. 557-564
In the early era of transplantation, it was common practice to exclude
diabetic patients since the outcome in such cases was usually poor. A
t our center in Malmo, Sweden, diabetic nephropathy was never regarded
as a contraindication. During the 22-year period from 1972 to 1993, 2
23 renal allografts were transplanted in 189 uremic diabetics, represe
nting 24 % of all renal transplant recipients (n = 788). The two subgr
oups - patients with and without diabetes did not differ significantly
in graft survival rates for the 22-year period, which was characteriz
ed by a successive improvement in the success rate that was especially
striking in the diabetic nephropathy subgroup. Among transplantations
performed before 1988, the overall patient survival rate was signific
antly lower in the diabetic subgroup than in the remainder. After 1988
(when a series of new procedures had been adopted), the patient survi
val rate in the diabetic subgroup was similar to that in the nondiabet
ic subgroup, a similarity that persisted for at least 5 years. The 1st
year post-transplant mortality rate was reduced in diabetic patients
from 24 % before 1988 to 0 % in those transplanted after 1988. In the
22-year period as a whole, cardiovascular or cerebrovascular events we
re the most common cause of death in both subgroups; the risk of cardi
ovascular or cerebrovascular death was reduced after 1988, and the rat
es were similar in both subgroups. The improved success rate of renal
transplantation in patients with diabetic nephropathy supports continu
ation of the renal transplant program, which is based on careful manag
ement of the early stages of the disease.